WHO ICTRP trial
The use of Contrast Enhanced Transesophageal Echocardiography in thoracic…
EUCTR2010-018767-42-IT · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2010-018767-42-IT |
|---|---|
| Public title | The use of Contrast Enhanced Transesophageal Echocardiography in thoracic endovascular aortic repair (TEVAR). Feasibility and safety of a new tool for intraoperative monitoring and follow up. - ND |
| Scientific title | The use of Contrast Enhanced Transesophageal Echocardiography in thoracic endovascular aortic repair (TEVAR). Feasibility and safety of a new tool for intraoperative monitoring and follow up. - ND |
| Primary sponsor | FONDAZIONE CENTRO S. RAFFAELE DEL MONTE TABOR |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | descending thoracic aorta diseases MedDRA version: 9.1 Level: SOC Classification code 10007541 |
| Interventions | Trade Name: SONOVUE Pharmaceutical Form: Powder and solvent for solution for infusion INN or Proposed INN: Sulfur hexafluoride Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: 2- |
| Registration date | Mar 3, 2010 |
| Secondary IDs | CEUS-TEVAR-29 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: